ubenimex has been researched along with Granulocytic Leukemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, F; Horinishi, H; Ishizuka, M; Matsuda, A; Shibuya, K; Takahashi, K; Takeuchi, T; Uchida, M; Umezawa, H | 1 |
Arimori, S; Komatsuda, M; Nagao, T; Shimizu, Y; Watanabe, K | 1 |
Asou, N; Emi, N; Hiraoka, A; Jinnai, I; Kageyama, S; Kanamaru, A; Kobayashi, T; Kuriyama, K; Matsuoka, A; Minami, S; Minato, K; Miyawaki, S; Murakami, H; Naoe, T; Oh, H; Ohmoto, E; Ohno, R; Saito, K; Sakamaki, H; Takahashi, I; Tanimoto, M; Tomonaga, M; Tsubaki, K; Yamada, O; Yoshida, M | 1 |
Tsukagoshi, S | 1 |
Kurita, S; Masaoka, T; Ogawa, N; Ota, K; Uzuka, Y; Yamada, K | 1 |
2 trial(s) available for ubenimex and Granulocytic Leukemia
Article | Year |
---|---|
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leucine; Leukemia, Myeloid; Logistic Models; Male; Mercaptopurine; Middle Aged; Multivariate Analysis; Prednisolone; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome | 1996 |
Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults.
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Humans; Leucine; Leukemia; Leukemia, Myeloid; Male; Middle Aged; Random Allocation | 1986 |
3 other study(ies) available for ubenimex and Granulocytic Leukemia
Article | Year |
---|---|
Effect of bestatin on syngeneic tumors in mice.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antibody-Dependent Cell Cytotoxicity; Cell Line; Colonic Neoplasms; Killer Cells, Natural; Leucine; Leukemia, Myeloid; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Spleen | 1984 |
The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Leucine; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged | 1980 |
[A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Animals; Female; Humans; Leucine; Leukemia; Leukemia P388; Leukemia, Myeloid; Lymphoma; Male; Mice; Middle Aged; T-Lymphocytes | 1987 |